Shanghai BiOligo Biotech Co., Ltd. (referred to as "BiOligo"), a leading supplier of in vitro diagnostics and nucleic acid drug raw materials, recently closed a RMB 300 million Series A financing. The funding was led by The Carlyle Group, a global leading
On September 26th, Peak Sports, a leading sports brand in China, announced a strategic investment of nearly RMB 1.5 billion from China Resources Guodiao Xiamen Consumption Fund, with participation from several state-owned fund companies such as CCB Trust
Xinyi Information Technology, a provider of Internet of Things (IoT) intelligent terminal system SoC chips, recently closed nearly RMB 500 million in its Series B financing. The funds will primarily be used to strengthen chip research and development, imp
OrbusNeich Medical Group Limited ("OrbusNeich"), a global leader in vascular intervention devices, recently announced it successfully raised $200 million, led by Shenzhen Capital Group, with participation from CCB International, Star River Capital, Wanhui
CBridge Capital, a healthcare-focused investment firm, recently announced its investment in Beijing Anhejialier Technology Co., Ltd. ("Anhejialier"), a leading company in the field of ultrasonic knives. This investment represents CBridge Capital's strong
Innovative drug development company Lynk Pharma recently announced the successful closing of a $50 million in its Series B financing. The round was led by Lilly Asian Ventures, with participation from New Alliance Capital and HeDa Investment., as well as
ZuoYi Technology, a leading domestic medical artificial intelligence system development company, recently announced the successful closing of a RMB 100 million Series B financing. The round was led by Qiming Venture Partners, with participation from well-
New SORL successfully closes a RMB 500 million Series A financing. The round was led by HengXu Capital, with participation from SPIC, AutoCapital, Ruijian Capital, as well as local state-owned enterprises like Wenzhou Transportation Group and upstream sup
Wenheyou successfully closed a significant Series B financing with investment from HongShan, IDG Capital, Warburg Pincus, Country Garden Venture Capital, GIC, and CEC Fund, amongst others. CEC Capital Group served as the exclusive financial advisor fo